Apogem Capital LLC Assembly Biosciences, Inc. Transaction History

Apogem Capital LLC

  • $303 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.13 - $3.46 $44,536 - $72,345
-20,909 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$3.14 - $3.9 $30,096 - $37,381
9,585 Added 84.64%
20,909 $73,000
Q2 2021

Aug 16, 2021
BUY
$3.8 - $4.56 $43,031 - $51,637
11,324 New
11,324 $44,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $815M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Apogem Capital LLC Portfolio

Follow Apogem Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apogem Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email